Clinical Trial Update: Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD) [Phase 2]

View source ↗

Summary

Shionogi is sponsoring a Phase 2 study of S-606001 as an add-on to enzyme replacement therapy in adults with late-onset Pompe disease. The trial is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-onset Pompe Disease
• Pompe Disease

Drugs mentioned

• S-606001 (S-606001)

Snippet

Sponsor: Shionogi | Conditions: Pompe Disease | Phase 2 | Status: RECRUITING